Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer

New England Journal of Medicine

Volumn 336, Issue 20, 1997, Pages 1416-1421

  Krainer, Michael ^a   Silva Arrieta, Sandra ^a   FitzGerald, Michael G ^a   Shimada, Akira ^c   Ishioka, Chikashi ^c   Kanamaru, Ryunosuke ^b   MacDonald, Deborah J ^a   Unsal, Hilal ^a   Finkelstein, Dianne M ^b   Bowcock, Anne ^d   Isselbacher, Kurt J ^a   Haber, Daniel A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TOHOKU UNIVERSITY   (Japan)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS;

ADULT; AGE OF ONSET; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENES, BRCA1; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; NEOPLASM PROTEINS; PREVALENCE; RISK; TRANSCRIPTION FACTORS;

EID: 17544403741     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199705153362003     Document Type: Article

References (28)

1. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
2. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266: 66-71.
3. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
4. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linkcd kindreds. Nat Genet 1996;12:333-7.
5. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
6. Rowell S, Newman B, Boyd J, King MC. Inherited predisposition to breast and ovarian cancer. Am J Hum Genet 1994;55:861-5.
7. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
8. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, eds, SEER cancer statistics review, 1973-1991: tables and graphs. Bethesda, Md.: National Cancer Institute, 1994. (NIH publication no. 94-2789.)
9. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 1991;48:232-42.
10. Futreal PA, Liu Q, Shattuck-Eidens D, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-2.
11. Castilla LH, Couch FJ, Erdos MR, et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 1994;8:387-91.
12. Simard J, Tonin P, Durocher F, et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 1994;8: 392-8.
13. Friedman LS, Ostermeyer EA, Szabo CI, et al.. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994;8:399-404.
14. Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCAl breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 1995; 273:535-41.
15. Langsten AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 1996;334:137-42.
16. FitzGerald MG, MacDonald DJ, Krainer M, et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 1996;334:143-9.
17. Struewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCAl 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995;11:198-200.
18. Offit K, Gilewski T, McGuire P, et al. Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 1996;347:1643-5.
19. Muto MG, Cramer DW, Tangir J, Berkowitz R, Mok S. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res 1996;56:1250-2.
20. Berman DB, Wagner-Costaias J, Schultz DC, Lynch HT, Daly M, Godwin AK. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 1996-58:1166-76.
21. Couch FJ, Farid LM, DeShano ML, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 1996;13: 123-5.
22. Phelan CM, Lancaster JM, Tonin P, et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 1996;13: 120-2.
23. Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and RRCA2. Nat Genet 1996;14:185-7.
24. Oddoux C, Struewing JP, Clayton CM, et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 1996;14:188-90.
25. Neuhausen S, Gilewski T, Norton L, et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 1996;13:126-8.
26. Ishioka C, Suzuki T, FitzGerald M, et al. Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc Natl Acad Sci U S A 1997;94:2449-53.
27. Mazoyer S, Dunning A, Serova O, et al. A polymorphic stop codon in BRCA2. Nat Genet 1996;14:253-4.
28. Tonin P, Weber B, Offit K, et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 1996;11:1179-83.